| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.04B | — | +6.2% |
| Cost of Revenue | $303.5M | — | +1.5% |
| Gross Profit | $736.6M | — | +8.3% |
| R&D Expense | $98.7M | — | +1.5% |
| SG&A Expense | $465.3M | — | +4.0% |
| Operating Income | $142.0M | — | +8.3% |
| Pre-tax Income | $148.9M | — | +6.0% |
| Income Tax | $36.1M | — | -23.5% |
| Net Income | $112.8M | — | +21.0% |
| EPS (Basic) | $1.58 | — | +24.4% |
| EPS (Diluted) | $1.57 | — | +23.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.06B | -3.2% | +21.4% |
| Accounts Receivable | $1.13B | +2.1% | +5.9% |
| Inventory | $214.9M | -5.0% | -12.8% |
| Current Assets | $2.66B | +1.5% | +10.5% |
| Total Assets | $6.31B | +1.3% | +3.5% |
| Current Liabilities | $1.91B | -0.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $151.0M | — | +186.7% |
| Capital Expenditures | $30.8M | — | +21.7% |
| Investing Cash Flow | -$131.6M | — | -420.3% |
| Financing Cash Flow | -$48.1M | — | +76.7% |
| Free Cash Flow | $120.3M | — | +339.1% |
| -4.3% |
| Total Liabilities | $2.16B | -0.9% | -6.2% |
| Stockholders' Equity | $4.15B | +2.5% | +9.4% |